Literature DB >> 26658028

Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells.

Saifur R Khan1, Naif Aljuhani2, Andrew G M Morgan1, Argishti Baghdasarian1, Richard P Fahlman3, Arno G Siraki4.   

Abstract

To combat tuberculosis (TB), host phagocytic cells need to survive against self-generating oxidative stress-induced necrosis. However, the effect of isoniazid (INH) in protecting cells from oxidative stress-induced necrosis has not been previously investigated. In this in vitro study, the cytotoxic effect of H2O2 generation using glucose oxidase (a model of oxidative stress) was found to be abrogated by INH in a concentration-dependent manner in HL-60 cells (a human promyelocytic leukemia cell). In cells treated with glucose oxidase, both ATP and mitochondrial membrane potential were found to be decreased. However, treatment with INH demonstrated small but significant attenuation in decreasing ATP levels, and complete reversal for the decrease in mitochondrial membrane potential. Quantitative proteomics analysis identified up-regulation of 15 proteins and down-regulation of 14 proteins which all together suggest that these proteomic changes signal for increasing cellular replication, structural integrity, ATP synthesis, and inhibiting cell death. In addition, studies demonstrated that myeloperoxidase (MPO) was involved in catalyzing INH-protein adduct formation. Unexpectedly, these covalent protein adducts were correlated with INH-induced cytoprotection in HL-60 cells. Further studies are needed to determine whether the INH-protein adducts were causative in the mechanism of cytoprotection.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Covalent binding; Cytoprotection; HL-60 cells; Hydrogen peroxide; Isoniazid; Myeloperoxidase

Mesh:

Substances:

Year:  2015        PMID: 26658028     DOI: 10.1016/j.cbi.2015.11.026

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.

Authors:  Chuan-Chin Huang; Mercedes C Becerra; Roger Calderon; Carmen Contreras; Jerome Galea; Louis Grandjean; Leonid Lecca; Rosa Yataco; Zibiao Zhang; Megan Murray
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

Review 2.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

3.  Identification of novel N-acetylcysteine derivatives for the treatment of hepatocellular injury.

Authors:  Shourong Liu; Yanmei Zhao; Ruoyu He; Limin Kong; Jianjun Xi; Jingjing Sun; Yidan Shao; Xuwang Pan; Jiankang Zhang; Rangxiao Zhuang
Journal:  Medchemcomm       Date:  2017-10-19       Impact factor: 3.597

Review 4.  The Role of Complement System and the Immune Response to Tuberculosis Infection.

Authors:  Heena Jagatia; Anthony G Tsolaki
Journal:  Medicina (Kaunas)       Date:  2021-01-20       Impact factor: 2.430

5.  Global protein expression dataset acquired during isoniazid-induced cytoprotection against H2O2 challenge in HL-60 cells.

Authors:  Saifur R Khan; Argishti Baghdasarian; Richard P Fahlman; Arno G Siraki
Journal:  Data Brief       Date:  2016-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.